ERC1 Antibody (Center) Blocking Peptide

Artikelnummer: ABT-BP9289C
Artikelname: ERC1 Antibody (Center) Blocking Peptide
Artikelnummer: ABT-BP9289C
Hersteller Artikelnummer: BP9289c
Alternativnummer: ABT-BP9289C-500UG
Hersteller: Abcepta
Kategorie: Proteine/Peptide
Alternative Synonym: ELKS/Rab6-interacting/CAST family member 1, ERC-1, Rab6-interacting protein 2, ERC1, ELKS, KIAA1081, RAB6IP2
Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport. The protein is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10,12)(q11,p13). Five transcript variants encoding different isoforms have been found for this gene.
NCBI: 23085
UniProt: Q8IUD2
Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP9289c was selected from the Center region of human ERC1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.